Special-Interest Sessions
Research, Clinical Research, drug development, Diseases, Therapies
Great Hall AD
(Ernest N. Morial Convention Center)
Bindu Kanapuru, MD
Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Vienna, VA
Andrea C. Baines, MD, PhD1* and Bindu Kanapuru, MD2*
1U.S. Food and Drug Administration, Silver Spring, MD
2Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Vienna, VA
Dan T. Vogl, MD
Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
Mona Elmacken, MD
U.S. Food and Drug Administration, Silver Spring, MD
Elizabeth L. Budde, MD, PhD
Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
Ashley Woods, MD
Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
Ehab L. Atallah, MD
Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
Dianne Pulte, MD
U.S. Food and Drug Administration, Silver Spring, MD
Raajit K Rampal, MD, PhD
Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY
Cara A. Rabik, MD, PhD
U.S. Food and Drug Administration, Silver Spring, MD
Bindu Kanapuru, MD
Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Vienna, VA
denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.